Skip to content
DataLookout
Menu

NCT06694077

Suprazygomatic Maxillary Nerve Block for Management of Postoperative Pain in Adenotonsillectomy Patients

StatusUnknown
PhasePhase 4
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 1 version: 1 with changes below.

  1. Minor Changed Registry marked status Unknown (sponsor has not verified the record since Oct 2024); last known: Not Yet Recruiting
  2. Study First Submitted
  • Minor: routine updates

Endpoints

Primary

the total amount of analgesic requirements during first the 24hr after two different blocks.
Timeframe: Postoperative 24 hours

Secondary (1)

Postoperative pain score, Faces, Legs, Activity, Cry, Consolability (FLACC)

Arms and interventions

Bupivacaine with DexamethasoneExperimental

bilateral suprazygomatic maxillary nerve block will be performed with 1 mL of 0.5% bupivacaine was added to 0.1 mg.kg-1 dexamethasone and diluted to 2 mL with 0.9% saline.

Bupivacaine onlyExperimental

bilateral suprazygomatic maxillary nerve block will be performed with 1 mL of 0.5% bupivacaine alone and diluted to 2 mL with 0.9% saline

Drugs: Bupivacaine with Dexamethasone, Bupivacaine only